Subject
Structural Biology,Biophysics
Reference25 articles.
1. Fuchs B.C., Hoshida Y., Fuji T., Wei L., Yamada S., Lauwers G.Y., McGinn C.M., DePeralta D.K., Chen X., Kuroda T., Lanuti M., Schmitt A.D., Gupta S., Crenshaw A., Onofrio R., et al. 2014. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology.
59 (4), 1577–1590.
2. Huang P., Xu X., Wang L., Zhu B., Wang X., Xia J. 2014. The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment. J. Cell. Mol. Med., 18 (2), 218–230.
3. Liu Z.C., Ning F., Wang H.F., Chen D.-Y., Cai Y.-N., Sheng H.-Y., Lash G.E., Liu L., Du J. 2017. Epidermal growth factor and tumor necrosis factor α cooperatively promote the motility of hepatocellular carcinoma cell lines via synergistic induction of fibronectin by NF-κB/p65. Biochim. Biophys. Acta Gen. Subj. 1861 (11, Pt. A), 2568–2582. https://doi.org/10.1016/j.bbagen.2017.08.010
4. Nikolova D., Chalovska V., Ivanova M.G., Nikolovska E., Volkanovska A., Orovchanec N., Kunovska S.K., Petrushevska G., Janevska V. 2018. Immunohistochemical expression of epidermal growth factor receptor in hepatocellular carcinoma. Pril. Makedon. Akad. Nauk Umet. Odd Med. Nauki. 39 (2–3), 21–28.
5. Xia H., Dai X., Yu H., Zhou S., Fan Z., Wei G., Tang Q., Gong Q., Bi F. 2018. EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: The mechanism and its implications in targeted therapy. Cell Death Dis.
9 (3), 269. https://doi.org/10.1038/s41419-018-0302-x
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献